Home
Conditions
Neoplasms, Nerve Tissue

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,299 public trials 1,289 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Completed

Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor

NCT01099540

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Samsung Cancer Center Seoul, South Korea

View Trial Details

Completed

Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging

NCT01884194

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +19 more
Locations: Charite Hospital Berlin Berlin, State of Berlin, Germany

View Trial Details

Completed

Safety Study of Modified Vaccinia Virus to Cancer

NCT00574977

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +36 more
Locations: University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo

NCT00574392

Conditions: Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +18 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma

NCT00289016

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: UCSD Cancer Center, Thornton Hospital La Jolla, California, United States

UCLA Los Angeles, California, United States

University of Colorado, Anschutz Cancer Pavillion Aurora, Colorado, United States

Hubert H Humphrey Cancer Center Robbinsdale, Minnesota, United States

View Trial Details

Completed

An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma

NCT01368276

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Rush University Medical Center Chicago, Illinois, United States

Indiana University Indianapolis, Indiana, United States

University of Iowa Hospitals & Clinics Iowa City, Iowa, United States

James Graham Brown Cancer Center Louisville, Kentucky, United States

View Trial Details

Completed

An Extension Protocol for the Extended Use of Talimogene Laherparepvec for Eligible Patients Who Participated in Study 002/03 (NCT00289016)

NCT02574260

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

NCT00185302

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Completed

Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer

NCT00006022

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: Norris Cotton Cancer Center Lebanon, New Hampshire, United States

Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma

NCT00121680

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Dallas, Texas, United States

Houston, Texas, United States

View Trial Details

Neoplasms, Nerve Tissue

Neoplasms, Nerve Tissue trial results

Related conditions